GGrantIndex
Sort

146,196 grants matching diabetes

Developing preclinical xenograft models in zebrafish.

$794,628
David Michael Langenau · Massachusetts General Hospital · R24 · FY2023 · OD

Developing preclinical xenograft models in zebrafish.

$794,628
David Michael Langenau · Massachusetts General Hospital · R24 · FY2022 · OD

Pediatric ECHORN Cohort Study: intergenerational factors that contribute to cardiovascular risk in the Eastern Caribbean

$794,567
Marcella Nunez-Smith · Yale University · R01 · FY2018 · HL

Decreasing Cardiometabolic Risk in Survivors of Childhood Cancer: Survivors engaged in Time-Restricted EatiNG after THerapy (STRENGTH)

$794,530
Danielle Friedman · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

Genetics of Coronary Artery Disease in Alaska Natives

$794,401
Medstar Research Institute · U01 · FY2005 · HL

Inhibitors and Probes of HIV-1 Cell Fusion

$794,394
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK

Colorado Nurse Family Heart Trial for the ENRICH program

$794,393
Mandy Atlee Allison · University Of Colorado Denver · UG3 · FY2023 · HL

Candidate Gene Studies of Obesity Guided by Whole Genome Association Data

$794,358
Joel N Hirschhorn · Boston Children'S Hospital · R01 · FY2011 · DK

One-compound, one-islet: A high-throughput platform for small-molecule discovery

$794,208
Bridget K Wagner · Broad Institute, Inc. · U01 · FY2019 · DK

Circulating Biomarker Consortium for Pancreatic Cancer Early Detection

$794,139
Brian Matthew Wolpin · Dana-Farber Cancer Inst · U01 · FY2017 · CA

EGF/Gastrin for Islet Regeneration

$794,040
Gerardo M. Castillo · Pharmain Corporation · R44 · FY2013 · DK

DC-Baltimore Center to Improve Child Health Disparities

$794,016
Children'S National Medical Center · P20 · FY2004 · MD

Metformin for chemoprevention of lung cancer in obese subjects at high risk

$794,005
Saikrishna Yendamuri · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA

CICADA: clinical informatics and computational approaches for drug-repositioning of AD/ADRD

$793,964
Yong Chen · University Of Pennsylvania · R56 · FY2021 · AG

Optimization and Pre-Clinical Studies of a Protein Therapeutic for Recruiting Brown Adipocytes

$793,958
Olivier Boss · Energesis Pharmaceuticals, Inc. · R44 · FY2017 · DK

J: NRSA Training Core

$793,955
Janice Lynn Gabrilove · Icahn School Of Medicine At Mount Sinai · TL1 · FY2024 · TR

Project 2

$793,949
Jeroen Roose · University Of California, San Francisco · P01 · FY2020 · AI

Prevention of corneal transplant rejection using AAV-BDRK-401 therapy

$793,930
Brian C Gilger · Bedrock Therapeutics, Inc. · R42 · FY2025 · EY

GENETIC CONTROL OF BB RAT AUTOIMMUNITY.

$793,890
University Of Washington · P01 · FY2004 · AI

Post Traumatic Stress Disorder and Accelerated Aging in Women

$793,882
Karestan C Koenen · Harvard School Of Public Health · R01 · FY2019 · MH

Epidemiology: Oxidative Stress and Early Atherosclerosis

$793,841
David R Jacobs · University Of Minnesota · R01 · FY2010 · HL

Functional MRI to Identify High-risk CKD Phenotypes

$793,840
Anand Srivastava · University Of Illinois At Chicago · R01 · FY2025 · DK

Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions

$793,800
Ying Yuan · University Of Tx Md Anderson Can Ctr · U24 · FY2023 · CA

Restoration of Endocrine Pancreas Function

$793,791
Massachusetts General Hospital · U19 · FY2001 · DK

Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases

$793,758
Mark A. Lemmon · Yale University · R35 · FY2019 · GM